Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction

NCT00755183 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Meibomian Gland Dysfunction

Interventions

DRUG: testosterone ophthalmic solution
DRUG: vehicle of testosterone ophthalmic solution

Sponsor

ORA, Inc.